Advocacy Actions

2019-09-27 > Beijing

Meeting with Technical Regulatory Affairs of Cosmetics Europe on cosmetics regulation

On 27 September, Cosmetics working group met with Gerald Renner, Director of Technical Regulatory Affairs of Cosmetics Europe, to exchange cosmetics regulation updates from both the European Union and China.

Read more
2019-09-25 > Beijing, Nanjing

Advocacy Letter to the Healthcare Security Administration of Jiangsu Province on 'Volume-Based Procurement'

The Healthcare Equipment (HCE) Working Group sent an advocacy letter to the Healthcare Security Administration (HSA) of Jiangsu Province, asking to postpone the second round of 'volume-based procurement' of high-value consumable medical devices.

Read more
2019-09-25 > Beijing

Meeting with Deputy Director General Zhang Chun of Fiscal, Financial Affairs and Credit Building Department, NDRC, on China’s Corporate Credit System

On 25th September, led by Secretary General Adam Dunnett, a European Chamber delegation paid a visit to the Fiscal, Financial Affairs and Credit Building (FFACB) Department, National Development and Reform Commission (NDRC), to meet with the deputy director general (DDG), Zhang Chun, on corporate social credit system issues. The director of the Foreign Investment Administration Department of the Ministry of Commerce, deputy directors of the National Public Credit Information Centre and representatives of the FFACB Department also attended the meeting.

Read more
2019-09-25 > Beijing, Southwest China

Meeting with Chairman of China Council for the Promotion of International Trade (CCPIT) Chengdu Sub-council

On 25th morning, Vice President Massimo Bagnasco and Beijing Chapter General Manager Carl Hayward received the representatives from Chengdu Municipal Government and met with Mr Chen Fu, chairman director of CCPIT Chengdu Sub-council.

Read more
2019-09-25 > Beijing

Comments to the NMPA's Notice on Matters Related to the First Batch of Implementation of the Unique Device Identification of Medical Devices (Call for Comment)

On 25th September, the medical devices sector submitted comments to the National Medical Products Administration on the Notice on Matters Related to the First Batch of Implementation of the Unique Device Identification of Medical Devices (Call for Comment).

Read more
2019-09-25 > Beijing

Comments to National Medical Products Administration (NMPA) on Catalog of Remaining Licensing Items in Medical Products Supervision System (Draft for Comments)

On 25 September, Comments on Catalog of Remaining Licensing Items in Medical Products Supervision System (Draft for Comments) were sent to National Medical Products Administration (NMPA).

Read more
2019-09-25 > Beijing

Dealing with Improper Protection of Consumer Right

Jointly organised an event with Marketing and Communications Forum, Legal and Competition Working Group (WG), Automotive WG, Paediatric Nutrition Desk, Food for Special Medical Purposes Advisory Committee and Cheese Industry Desk, and invited Catherine Guo, Senior Partner at King & Capital Law Firm, and former Journalist from Xinhua and CCTV, to present the topic on how to deal with improper protection of consumer rights.

Read more
2019-09-24 > Beijing

Chinese-German Dialogue on Quality Infrastructure in the Field of Medical Devices

The Healthcare Equipment (HCE) Working Group participated in the Chinese-German Dialogue on Quality Infrastructure in the field of medical devices, co-organised by the German Federal Ministry for Economic Affairs and Energy (BMWi) and the Chinese National Medical Products Administration (NMPA).

Read more
2019-09-24 > Beijing

COCIR and HCE Members Contribute the 10th China International Medical Device Regulatory(CIMDR) Forum in Suzhou

As the co-supporter of the 10th China International Medical Device Regulatory (CIMDR) Forum in Suzhou, COCIR and several members of the Healthcare Equipment Working Groups attended the conference as the moderator and speaker for plenary and sub-forums.

Read more